Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pericarditis | 1 | 2023 | 135 | 0.800 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2015 | 143 | 0.460 |
Why?
|
Angina Pectoris | 4 | 2013 | 969 | 0.390 |
Why?
|
Endocarditis | 1 | 2015 | 351 | 0.380 |
Why?
|
Coronary Occlusion | 1 | 2011 | 309 | 0.290 |
Why?
|
Angioplasty, Balloon, Coronary | 6 | 2013 | 1880 | 0.290 |
Why?
|
Glycoproteins | 1 | 2011 | 2208 | 0.210 |
Why?
|
Ventricular Remodeling | 2 | 2022 | 1261 | 0.210 |
Why?
|
Stem Cell Transplantation | 1 | 2011 | 1599 | 0.200 |
Why?
|
Atrial Flutter | 2 | 2014 | 258 | 0.200 |
Why?
|
Ischemia | 1 | 2011 | 1893 | 0.200 |
Why?
|
Electric Countershock | 2 | 2014 | 537 | 0.190 |
Why?
|
Hypothyroidism | 1 | 2006 | 665 | 0.190 |
Why?
|
Fractional Flow Reserve, Myocardial | 2 | 2022 | 329 | 0.180 |
Why?
|
Thoracic Surgical Procedures | 2 | 2014 | 348 | 0.180 |
Why?
|
Antigens, CD | 1 | 2011 | 4000 | 0.170 |
Why?
|
Coronary Artery Bypass | 4 | 2011 | 2272 | 0.170 |
Why?
|
Shock, Cardiogenic | 1 | 2006 | 734 | 0.170 |
Why?
|
Aortic Valve Stenosis | 3 | 2022 | 2065 | 0.170 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2014 | 784 | 0.170 |
Why?
|
Peptides | 1 | 2011 | 4354 | 0.160 |
Why?
|
Coronary Artery Disease | 5 | 2022 | 6659 | 0.160 |
Why?
|
Stem Cells | 1 | 2011 | 3523 | 0.150 |
Why?
|
Angina, Unstable | 3 | 2011 | 926 | 0.150 |
Why?
|
Death, Sudden, Cardiac | 1 | 2004 | 1572 | 0.130 |
Why?
|
Atrial Appendage | 1 | 2020 | 292 | 0.130 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2004 | 1717 | 0.130 |
Why?
|
Stroke Volume | 4 | 2023 | 5523 | 0.130 |
Why?
|
International Classification of Diseases | 1 | 2021 | 894 | 0.130 |
Why?
|
Coronary Disease | 2 | 2007 | 5990 | 0.120 |
Why?
|
Atrial Fibrillation | 4 | 2020 | 5209 | 0.120 |
Why?
|
Defibrillators, Implantable | 1 | 2004 | 1499 | 0.120 |
Why?
|
Ventricular Function, Left | 3 | 2023 | 3880 | 0.120 |
Why?
|
Kidney Failure, Chronic | 1 | 2007 | 2471 | 0.120 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2282 | 0.110 |
Why?
|
Heart Failure | 4 | 2023 | 11847 | 0.110 |
Why?
|
Coronary Circulation | 1 | 2019 | 1577 | 0.110 |
Why?
|
Hyperbaric Oxygenation | 2 | 2004 | 166 | 0.100 |
Why?
|
Catheter Ablation | 2 | 2014 | 2758 | 0.090 |
Why?
|
Coronary Restenosis | 2 | 2004 | 426 | 0.090 |
Why?
|
Myocardial Infarction | 4 | 2009 | 11891 | 0.080 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2020 | 2128 | 0.080 |
Why?
|
Incidence | 2 | 2023 | 21392 | 0.080 |
Why?
|
Myocardial Revascularization | 1 | 2013 | 841 | 0.080 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2017 | 1311 | 0.080 |
Why?
|
Diabetes Mellitus | 1 | 2007 | 5889 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2013 | 12293 | 0.070 |
Why?
|
Diabetic Angiopathies | 1 | 2011 | 822 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2020 | 3620 | 0.060 |
Why?
|
Humans | 27 | 2023 | 760621 | 0.060 |
Why?
|
Genetic Testing | 1 | 2017 | 3531 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4541 | 0.060 |
Why?
|
Hospitalization | 2 | 2023 | 10790 | 0.060 |
Why?
|
Autoimmune Diseases | 1 | 2016 | 2250 | 0.060 |
Why?
|
Iran | 1 | 2007 | 738 | 0.060 |
Why?
|
Middle Aged | 14 | 2023 | 220352 | 0.050 |
Why?
|
Coronary Angiography | 3 | 2011 | 4563 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Aged | 13 | 2023 | 169152 | 0.050 |
Why?
|
Male | 16 | 2023 | 359744 | 0.040 |
Why?
|
Risk Factors | 8 | 2020 | 74359 | 0.040 |
Why?
|
Hypertension | 1 | 2020 | 8594 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8624 | 0.040 |
Why?
|
Myocardial Ischemia | 1 | 2009 | 2164 | 0.040 |
Why?
|
Health Status | 1 | 2011 | 4081 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15289 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2020 | 65017 | 0.040 |
Why?
|
Female | 15 | 2023 | 391270 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2017 | 224 | 0.030 |
Why?
|
Age Factors | 3 | 2011 | 18416 | 0.030 |
Why?
|
Calcinosis | 1 | 2005 | 1476 | 0.030 |
Why?
|
Gene Duplication | 1 | 2017 | 313 | 0.030 |
Why?
|
Myocardial Perfusion Imaging | 1 | 2022 | 571 | 0.030 |
Why?
|
Patients | 1 | 2021 | 906 | 0.030 |
Why?
|
Anticoagulants | 2 | 2020 | 4897 | 0.030 |
Why?
|
Microcirculation | 1 | 2019 | 1278 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15757 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2023 | 58995 | 0.030 |
Why?
|
Electrocardiography | 1 | 2007 | 6414 | 0.030 |
Why?
|
Risk | 2 | 2020 | 9631 | 0.030 |
Why?
|
Societies, Medical | 2 | 2014 | 3905 | 0.020 |
Why?
|
Administration, Oral | 1 | 2020 | 4035 | 0.020 |
Why?
|
Warfarin | 1 | 2000 | 1518 | 0.020 |
Why?
|
Follow-Up Studies | 4 | 2022 | 39261 | 0.020 |
Why?
|
Patient Care Team | 1 | 2023 | 2511 | 0.020 |
Why?
|
Prognosis | 2 | 2013 | 29658 | 0.020 |
Why?
|
Prospective Studies | 4 | 2022 | 54303 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2005 | 3334 | 0.020 |
Why?
|
Cerebral Hemorrhage | 1 | 2020 | 2660 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2004 | 8056 | 0.020 |
Why?
|
Pilot Projects | 1 | 2021 | 8555 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8482 | 0.020 |
Why?
|
Cross-Cultural Comparison | 1 | 2011 | 633 | 0.020 |
Why?
|
Survival Rate | 2 | 2013 | 12808 | 0.020 |
Why?
|
Heart Diseases | 1 | 2020 | 2809 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2020 | 80372 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2009 | 597 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5425 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14660 | 0.020 |
Why?
|
Insulin | 2 | 2011 | 6597 | 0.020 |
Why?
|
Thrombosis | 1 | 2020 | 3052 | 0.020 |
Why?
|
Adult | 3 | 2011 | 219994 | 0.020 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 25942 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2022 | 6465 | 0.020 |
Why?
|
Death | 1 | 2009 | 678 | 0.020 |
Why?
|
Sex Factors | 2 | 2011 | 10547 | 0.020 |
Why?
|
Coronary Stenosis | 1 | 2011 | 820 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2017 | 4938 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4166 | 0.010 |
Why?
|
Risk Assessment | 2 | 2014 | 24123 | 0.010 |
Why?
|
Genetic Variation | 1 | 2017 | 6551 | 0.010 |
Why?
|
Time Factors | 3 | 2011 | 40165 | 0.010 |
Why?
|
Statistics as Topic | 1 | 1986 | 2362 | 0.010 |
Why?
|
Diabetes Complications | 1 | 1986 | 1341 | 0.010 |
Why?
|
Aortic Diseases | 1 | 2005 | 736 | 0.010 |
Why?
|
Life Style | 1 | 2011 | 3896 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6544 | 0.010 |
Why?
|
Hypoglycemic Agents | 1 | 2011 | 3150 | 0.010 |
Why?
|
Odds Ratio | 1 | 2011 | 9716 | 0.010 |
Why?
|
Stroke | 1 | 2020 | 9962 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13981 | 0.010 |
Why?
|
Mitral Valve Insufficiency | 1 | 1986 | 1419 | 0.010 |
Why?
|
Comorbidity | 1 | 2011 | 10551 | 0.010 |
Why?
|
Coronary Vessels | 1 | 1986 | 3112 | 0.010 |
Why?
|
Cross-Over Studies | 1 | 2000 | 2061 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2009 | 14495 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2002 | 5201 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2002 | 8552 | 0.010 |
Why?
|
Chronic Disease | 1 | 2000 | 9287 | 0.000 |
Why?
|
Concepts
(130)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_